Wall Street Split on Quantum Computing Bet

Wall Street remains deeply divided over quantum computing’s near-term viability despite its transformative potential in drug discovery, finance, and AI. Experts agree the technology could revolutionize risk modeling and machine learning but warn practical, scalable applications are still years away. Financial firms are split on investment strategies, with some doubling down on R&D while others adopt a wait-and-see approach amid elusive breakthroughs. The lack of immediate commercial returns has intensified skepticism, though proponents argue long-term gains justify sustained funding. Global finance’s hesitation reflects broader uncertainty about quantum’s timeline, as firms weigh speculative promise against near-term profitability pressures.